tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

IHH Director Mehmet Ali Aydinlar Trims Stake but Remains Major Shareholder

Story Highlights
  • IHH Healthcare director Mehmet Ali Aydinlar sold 1.65 million shares in two December transactions.
  • Despite the disposals, Aydinlar keeps significant direct and indirect stakes, remaining a key shareholder in IHH.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
IHH Director Mehmet Ali Aydinlar Trims Stake but Remains Major Shareholder

Claim 70% Off TipRanks Premium

IHH Healthcare Bhd ( (IHHHF) ) has provided an update.

IHH Healthcare Berhad has disclosed that its non-executive director, Mr. Mehmet Ali Aydinlar, disposed of a total of 1,647,300 ordinary shares in the company in two separate transactions on 29 and 30 December 2025, at prices of RM8.556 and RM8.567 per share, respectively. Following these disposals, Aydinlar retains substantial direct and indirect interests in IHH through various nominee and custodial accounts, indicating that while his personal stake has been trimmed slightly, he remains a significant shareholder, a point of interest for investors monitoring board-member ownership levels and governance alignment.

More about IHH Healthcare Bhd

IHH Healthcare Berhad is a Malaysia-based multinational healthcare provider, operating hospitals and related healthcare services across key markets including Asia and beyond. The group focuses on private healthcare delivery through a network of medical facilities, offering a wide range of clinical and specialist services to patients and positioning itself as a major player in the regional healthcare industry.

For an in-depth examination of IHHHF stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1